Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $118.74 million. The enterprise value is $611.04 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 161.82 million shares outstanding. The number of shares has increased by 2.34% in one year.
| Current Share Class | 161.82M |
| Shares Outstanding | 161.82M |
| Shares Change (YoY) | +2.34% |
| Shares Change (QoQ) | +0.96% |
| Owned by Insiders (%) | 2.14% |
| Owned by Institutions (%) | 67.75% |
| Float | 123.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.33 |
| PS Ratio | 0.36 |
| Forward PS | n/a |
| PB Ratio | -0.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.92 |
| EV / EBITDA | 8.07 |
| EV / EBIT | 8.29 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.34
| Current Ratio | 3.34 |
| Quick Ratio | 3.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | 7.51 |
| Debt / FCF | n/a |
| Interest Coverage | 2.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.03% |
| Return on Invested Capital (ROIC) | 14.74% |
| Return on Capital Employed (ROCE) | 26.41% |
| Revenue Per Employee | $1.26M |
| Profits Per Employee | -$127,842 |
| Employee Count | 253 |
| Asset Turnover | 0.83 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $56.31 million in taxes.
| Income Tax | 56.31M |
| Effective Tax Rate | 234.95% |
Stock Price Statistics
The stock price has decreased by -89.52% in the last 52 weeks. The beta is 0.37, so IRWD's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -89.52% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 3.31 |
| Relative Strength Index (RSI) | 32.74 |
| Average Volume (20 Days) | 3,924,711 |
Short Selling Information
The latest short interest is 8.80 million, so 5.44% of the outstanding shares have been sold short.
| Short Interest | 8.80M |
| Short Previous Month | 11.64M |
| Short % of Shares Out | 5.44% |
| Short % of Float | 7.13% |
| Short Ratio (days to cover) | 2.13 |
Income Statement
In the last 12 months, IRWD had revenue of $317.68 million and -$32.34 million in losses. Loss per share was -$0.20.
| Revenue | 317.68M |
| Gross Profit | 308.51M |
| Operating Income | 73.71M |
| Pretax Income | 88.16M |
| Net Income | -32.34M |
| EBITDA | 75.71M |
| EBIT | 73.71M |
| Loss Per Share | -$0.20 |
Full Income StatementBalance Sheet
The company has $108.48 million in cash and $599.08 million in debt, giving a net cash position of -$490.60 million or -$3.03 per share.
| Cash & Cash Equivalents | 108.48M |
| Total Debt | 599.08M |
| Net Cash | -490.60M |
| Net Cash Per Share | -$3.03 |
| Equity (Book Value) | -334.05M |
| Book Value Per Share | -2.08 |
| Working Capital | 112.48M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 97.11%, with operating and profit margins of 23.20% and -10.18%.
| Gross Margin | 97.11% |
| Operating Margin | 23.20% |
| Pretax Margin | 7.54% |
| Profit Margin | -10.18% |
| EBITDA Margin | 23.83% |
| EBIT Margin | 23.20% |
| FCF Margin | n/a |